The somatic mutations identified in these HCCs affected the canonical signal transduction and tumor-suppressor pathways involved in thyroid cancer, including the RAS/RAF/MAPK and PI3K/AKT/mTOR cascades (55% of the tumors) and those involved in DNA damage and repair (38%). This evidence concerns the gene PIK3CA and thyroid gland carcinoma.